Cargando…
Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal Study
Background. Emerging evidences have shown a close interplay between obesity, diabetes, and intestinal flora disturbance. Dipeptidyl peptidase-4 inhibitor, exemplified by sitagliptin, is highly efficacious in treating type 2 diabetes (T2DM), yet little is known if sitagliptin exerts beneficial effect...
Autores principales: | Yan, Xinfeng, Feng, Bo, Li, Peicheng, Tang, Zhaosheng, Wang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007364/ https://www.ncbi.nlm.nih.gov/pubmed/27631013 http://dx.doi.org/10.1155/2016/2093171 |
Ejemplares similares
-
The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance
por: Yan, Xinfeng, et al.
Publicado: (2017) -
Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment
por: Wang, Lin, et al.
Publicado: (2016) -
Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans
por: Ohashi, Kaoru, et al.
Publicado: (2015) -
Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
por: Zhang, Xiuying, et al.
Publicado: (2013) -
Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy
por: Sun, Zhongwen, et al.
Publicado: (2023)